CGS-27023A

Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl](3-pyridinylmethyl)amino]-3-methyl-, (2R)-

CGS-27023A

N-Hydroxy-N~2~-[(4-methoxyphenyl)sulfonyl]-N~2~-(3-pyridinylmethyl)-D-valinamid

N-Hydroxy-N~2~-[(4-methoxyphenyl)sulfonyl]-N~2~-(3-pyridinylmethyl)-D-valinamide

N-Hydroxy-N~2~-[(4-méthoxyphényl)sulfonyl]-N~2~-(3-pyridinylméthyl)-D-valinamide

(2R)-N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide

(2R)-N-hydroxy-3-methyl-2-[N-(pyridin-3-ylmethyl)(4-methoxybenzene)sulfonamido]butanamide

(2R)-N-hydroxy-3-methyl-2-[N-(pyridin-3-ylmethyl)4-methoxybenzenesulfonamido]butanamide

161314-70-1

161314-82-5

3MP-HAV-MSB

72 kDa type IV collagenase

ATS4_HUMAN

CGS

CGS 27023A

CGS27023A

hydroxamate analogue 1

Interstitial collagenase

LEF_BACAN

Lethal factor

Matrix metalloproteinase-9

MFCD00932462

MMP13_HUMAN

MMP1_HUMAN

MMP2_HUMAN

MMP3_HUMAN

MMP9_HUMAN